Endocrine Society RPHR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Right arrow Help viewing high resolution images
Right arrow Return to article
(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.



FIG. 1. (facing page). Activation and function of the positive transcription elongation factor-b (P-TEFb) (cyclin T/Cdk9) in cardiac muscle hypertrophy. (Upper panel) Schematic representation of the RNA polymerase II (RNAPII) phosphorylation-dephosphorylation cycle and its modulation by physiological, pharmacological, and genetic triggers of hypertrophy. Upstream signals (a) and direct manipulations of Cdk9 activity (b-d) correspond to data illustrated in the lower panels. [Reproduced and modified from Sano M, Abdellatif M, Oh H, Xie M, Bagella L, Giordano A, Michael LH, DeMayo FJ, Schneider MD 2002 Activation and function of cyclin T-Cdk9 (positive transcription elongation factor-b) in cardiac muscle-cell hypertrophy. Nature Med 8:1310–1317, with permission of the Nature Publishing Group.]





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals